Mode
Text Size
Log in / Sign up
N/A Completed N=900 Randomized Single-blind Prevention

HOPE Social Media Intervention for HIV Testing and Studying Social Networks

Source: ClinicalTrials.gov NCT02944877 ↗
Enrolled (actual)
900
Serious AEs
0.0%
Results posted
Oct 2024
Primary outcomePrimary: Number of Participants Requesting HIV Self-Testing — 130; 102 Participants

Summary

This study [HOPE: Harnessing Online Peer Education] seeks to determine the efficacy of using online social networks to scale peer community leader models to increase HIV prevention within African-American and Latino men who have sex with men. The peer community leader model, which teaches community popular opinion leaders about how to disseminate behavior changes messages throughout the community, has been proven to increase HIV prevention behaviors. Social media and online communities, such as Facebook, may be a cost-effective platform for scaling these models. Primarily upper middle-class White populations used the Internet in its early years, however, Internet use within African-American and Latino households has recently increased dramatically, especially on social media. People using the Internet may be at the highest risk for contracting HIV and are using novel Internet approaches to find sex partners, such as through social media. This is the first study to examine the effectiveness of the HOPE social media intervention to increase HIV testing among at-risk groups in the United States.

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants Requesting HIV Self-Testing
130; 102

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older
  • Male
  • Sexually active with another man in the last 12 months
  • Willing and capable of understanding and assenting to an online informed consent form
  • Has (or willing to create) a social media page.

Exclusion Criteria

  • Does not satisfy inclusion criteria
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02944877). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search